Get a real taste and understanding of the business and culture of one of the world's great research-based cellular and gene therapy discovery and development companies.
EXPLORE MORECreative Biolabs has a tradition of commitment. To achieve efficient execution and regulatory approval, we offer careful considerations of your program for the development of a cellular or gene therapy product – now and in the future.
EXPLORE MORE HighlightsWe focus on unmet needs and develop novel cellular and gene drugs and solutions that offer significant benefits over existing options.
EXPLORE MORE HighlightsTo accelerate advanced breakthroughs of your projects, we offer broad range of platforms which enable our clients be free to tackle problems with cutting-edge technologies from different angles and in different methods.
EXPLORE MORE HighlightsUse the resources in our library to help you understand your options and make critical decisions for your study. We offer oncolytic virus, CAR-T, and dendritic cell related documents, as well as newsletter. If you don't find the answers you're looking for, contact us for additional assistance.
EXPLORE MORE HighlightsAll products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
Based on the continuous development of CAR-T therapies with CD24-targeting antibodies, Creative Biolabs has developed a comprehensive series of CD24 molecule-related products through the design and construction of CAR, including CAR vector products, CAR BiTE products, CAR cell products, CAR mRNA, etc. You can filter the keywords below to find the products you need.
CD24, as a cell adhesion molecule, is a protein encoded by the human CD24 gene. It is also known as a cluster of differentiation 24 or thermostable antigen CD24. Studies have shown that CD24 is expressed on the surface of B lymphocytes, differentiated neuroblasts, neutrophils, and neutrophil precursors. Functional studies have shown that CD24 contributes to downstream signaling networks as well as neurodevelopment. In addition, it induces apoptosis by cross-linking on the surface of neutrophils.
Anti-CD24 CAR-T Expression Test
With appropriate assays, CD24 expression levels in different cell lines can be quantified. Creative Biolabs offers different CAR expression assays, including flow cytometry, western blotting, and CAR-specific monoclonal antibody development, to help you achieve chimeric antigen receptor (CAR) expression and stability testing.
Fig.1 Analysis of CD24 antigen expression in different ovarian cancer cell lines using flow cytometric. The results showed that the CD24 expression of SKOV3 and OVCAR3 cells was relatively higher than that of A2780 and 293T cells.1
Anti-CD24 CAR-T Cytokine Release Test
ELISA can quantify CD24-CAR-NK-92 cell activation to measure IFNγ secretion levels. Based on the CellRapeutics™ platform, Creative Biolabs offers a range of cytokine enzyme-linked immunosorbent assay (ELISA) kits for the detection of different cytokine secretions.
Fig.2 IFNγ levels of anti-CD24-CAR-NK-92 cells co-incubated with CD24-expressing cancer cells were determined by ELISA.1
Anti-CD24 CAR-T In Vitro Cytotoxicity Assay
Studies have shown that CD24-specific NK cells have a high killing efficiency against OVCAR3 and SKOV3 cells. Creative Biolabs uses cytotoxicity analysis to assess the toxicity of CAR-transplanted T cells or NK cells to normal cells. In addition, we can also co-express CARs with appropriate suicide genes to kill cancer cells without affecting normal cells.
Fig.3 Cytotoxicity of anti-CD24-CAR-NK-92 cells. The results showed that anti-CD24-CAR conferred the ability of NK-92 cells to specifically kill antigen-presenting cells.1
Leveraging our proprietary CellRapeutics™ platform, Creative Biolabs provides one-stop, customized CD24 CAR-T in vivo testing services to customers worldwide. Our CD24 CAR-T in vivo assays cover a full range of high-quality services, from animal model construction to in vivo efficacy and toxicity evaluation. You can find more information about what you are interested in the CAR-T Preclinical In Vivo Testing unit.
Reference
Loading...
| CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
| CAR-YF163 | Anti-CD24 (CBL-YF052) h(4-1BB-CD3ζ) CAR, pCDCAR1 | Human | CBL-YF052 | Mouse | scFv-4-1BB-CD3ζ | Lentiviral vector | T cell | ||
| CAR-YF164 | Anti-CD24 (CBL-YF052) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBL-YF052 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
| XS-0622-ZP3496 | Anti-CD24 h(VHH1-VHH2-4-1BB-CD3ζ) Biepitopic CAR, pCDCAR1 | VHH1-VHH2-4-1BB-CD3ζ | Lentiviral vector | T Cell | |||||
| XS-0822-YF91 | Anti-Human CD24 (XW-91) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-91 | Mouse | scFv-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
| XS-0822-YF1011 | Anti-Human CD24 (XW-91) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-91 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
| XS-0822-YF1931 | Anti-Human CD24 (XW-91) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-91 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
| XS-1122-YF91 | Anti-CD24 KIR CAR (scFv-KIR2DS2-DAP12, XW-91), pCDCAR1 | Human | XW-91 | Mouse | scFv-KIR2DS2 TM&ICD-2A-DAP12 | Lentiviral vector | T Cell | ||
| XS-1122-YF1011 | Anti-CD24 TCR-ABR (scFv-TCRα, XW-91) CAR Plasmid, pCDCAR1 | Human | XW-91 | Mouse | scFv-TCRα | Lentiviral vector | T Cell | ||
| XS-1122-YF1931 | Anti-CD24 TCR-ABR (scFv-TCRβ, XW-91) CAR Plasmid, pCDCAR1 | Human | XW-91 | Mouse | scFv-TCRβ | Lentiviral vector | T Cell | ||
| XS-1122-YF2851 | Anti-CD24 TCR-ABR (scFv-CD3γ, XW-91) CAR Plasmid, pCDCAR1 | Human | XW-91 | Mouse | scFv-CD3γ | Lentiviral vector | T Cell | ||
| XS-1122-YF3771 | Anti-CD24 TCR-ABR (scFv-CD3δ, XW-91) CAR Plasmid, pCDCAR1 | Human | XW-91 | Mouse | scFv-CD3δ | Lentiviral vector | T Cell | ||
| XS-1122-YF4691 | Anti-CD24 TCR-ABR (scFv-CD3ε, XW-91) CAR Plasmid, pCDCAR1 | Human | XW-91 | Mouse | scFv-CD3ε | Lentiviral vector | T Cell | ||
| XS-1122-YF5611 | Anti-CD24 (XW-91) h(CD28-CD3ζ) CAR, pAAV | Human | XW-91 | Mouse | scFv-CD28-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
| XS-1122-YF6531 | Anti-CD24 (XW-91) h(41BB-CD3ζ) CAR, pAAV | Human | XW-91 | Mouse | scFv-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
| XS-1122-YF7451 | Anti-CD24 (XW-91) h(CD28-41BB-CD3ζ) CAR, pAAV | Human | XW-91 | Mouse | scFv-CD28-41BB-CD3ζ | Adeno-associated viral (AAV) vector | T Cell | ||
| XS-1222-ZP432 | CD24 (SELP Receptor) h(CD28-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CD24-CD28-CD6ζ | Lentiviral vector | T cell | ||||
| XS-1222-ZP1832 | CD24 (SELP Receptor) h(41BB-CD3ζ) Ligand-based CAR, pCDCAR1 | Human | CD24-41BB-CD6ζ | Lentiviral vector | T cell | ||||
| XS-0123-ZP778 | Anti-CD24 (SWA11) h(scFv-CD3ε) TRuC, pCDTRC1 | Human | SWA11 | Mouse | scFv-CD3ε | Lentiviral vector | T cell | ||
| XS-0323-ZP778 | Anti-CD24 (SWA11 scFv-CD28TM-CD79β) CBCR(CAR-B), pCDCAR1 | Human | SWA11 | Mouse | scFv-CD28TM-CD79β | Lentiviral vector | T cell | CAR-B Vector | |
| XS-0923-LX103 | Anti-hCD24 (CD28-41BB-CD3ζ) CAR-duplex CTLA4 pCDCAR1 Vector | Human | X9X-72 | scFv-CD28-41BB-CD3ζ-duplex CTLA4 | Lentiviral vector | T cell | CAR-T |
NEWSLETTER
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTER
NEW SOLUTION
CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTION
NOVEL TECHNOLOGY
Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGY
NEW SOLUTION
Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION
